Searchable abstracts of presentations at key conferences in endocrinology

ea0025p336 | Thyroid | SFEBES2011

Variation in levels of skewed X chromosome inactivation represents a shared pathogenic pathway for the common autoimmune thyroid diseases

Simmonds Matthew , Brand Oliver , Newby Paul , Jackson Laura , Hargreaves Chantal , Carr-Smith Jackie , Franklyn Jayne , Gough Stephen

Graves’ disease (GD) and Hashimotos’ thyroiditis (HT), two of the most common autoimmune thyroid diseases (AITD), are caused by both shared and disease specific genetic determinants. In females one copy of the X chromosome is randomly inactivated, and although inactivation should occur with a parent of origin ratio of 50:50, skewed X chromosome inactivation (XCI) can occur, whereby >80% of a specific copy of the X chromosome is inactivated. Increased skewed XCI i...

ea0021oc5.7 | Steroids and thyroid | SFEBES2009

X chromosome inactivation: the key to the female preponderance in Graves' disease?

Simmonds Matthew , Newby Paul , Jackson Laura , Hargreaves Chantal , Brand Oliver , Carr-Smith Jackie , Franklyn Jayne , Gough Stephen

Graves’ disease (GD) affects >2% of the population and occurs more frequently in females than males. Several hypotheses have been put forward to explain the female preponderance including increased immune responsiveness, gonadal steriods, sex chromosome susceptibility loci and, more recently, skewed X inactivation (XCI). XCI occurs in females causing one of their X chromosomes to be randomly inactivated enabling dosage compensation with males who only have one copy of...

ea0015p176 | Endocrine tumours and neoplasia | SFEBES2008

A novel mechanism of thyroid tumorigenesis based on inactivation of p53 by the PTTG-binding factor PBF

Read Martin , Turnell Andy , Kim Dae , Watkins Rachel , Smith Vicki , Fong Jim , Watkinson John , Boelaert Kristien , Franklyn Jayne , McCabe Chris

The pituitary tumor transforming gene binding factor (PBF) is a poorly characterised gene that is over-expressed in pituitary and thyroid tumours. Recently, we showed that subcutaneous expression of PBF elicits tumours in nude mice, and expression correlates with thyroid tumour recurrence in man. Given the established role of ionising radiation in thyroid tumourigenesis, we have now investigated the relationship between PBF and the tumour suppressor gene p53, a central compone...

ea0015p201 | Growth and development | SFEBES2008

Expression of thyroid hormone transporters in the human fetal cerebral cortex

Chan Shiao , Martin-Santos Azucena , Loubiere Laurence , Vasilopoulou Elisavet , James Sally , McCabe Chris , Franklyn Jayne , Kilby Mark

The importance of thyroid hormone (TH) transporters to central nervous system (CNS) development has been highlighted by reports of severe global neurological impairment associated with mutations in the potent TH transporter, MCT8. Even subclinical maternal hypothyroidism in early pregnancy has been associated with long-term neurodevelopmental delay in the offspring suggesting that TH is crucial for early fetal brain development. The cellular entry of TH requires the function o...

ea0013p129 | Growth and development | SFEBES2007

Pituitary tumor transforming gene (PTTG), separase and Rad21 in neural cell growth

Pemberton Helen , Franklyn Jayne , Boelaert Kristien , Chan Shiao , Kim Caroline , Cheng Sheue-Yann , Kilby Mark , Mccabe Christopher

The key mitotic regulator pituitary tumor transforming gene (PTTG) is expressed at low levels in fetal brain compared with adult, and modulates the proliferation of human embryonic neuronal N-Tera2 (NT2) cells. We examined the function and expression of PTTG’s interacting partner separase, along with Rad21, the functional component of cohesin, which is cleaved by separase following interaction with PTTG. In contrast to PTTG, the cleaved forms of separase and Rad21 were hi...

ea0044oc3.3 | Thyroid and Neoplasia | SFEBES2016

Post-Radioiodine Graves’ Management: The Pragma-Study

Perros Petros , Dayan Colin , Vaidya Bijay , Williams Graham , Lazarus John H , Hickey Janis , Willis Debbie , Archer Natasha , Franklyn Jayne , Basu Ansu

Introduction: Radioiodine (RI) is a safe and effective treatment for Graves’ disease. In the months following RI different strategies are used to gain control of thyroid status, although there is no evidence base as to the optimal approach.Objectives: To compare the incidence of dysthyroidism post-RI between three principal management strategies employed by clinicians.Study design and methods: Retrospective, observational, mul...

ea0034p397 | Thyroid | SFEBES2014

Examination of PTTG-binding factor mRNA reveals functional miRNA target sites and exon-skipping splice variants in thyroid cells

Read Martin , Longman Jo , Fletcher Alice , Smith Vicki , Watkins Rachel , Modasia Bhavika , Poole Vikki , Imruetaicharoenchoke Waraporn , Franklyn Jayne , Boelaert Kristien , McCabe Christopher

Dysregulation of the processing and stability of mRNA encoding oncogenes or tumour suppressor proteins is a critical event in the pathogenesis of cancer. Previously, we demonstrated that the proto-oncogene PTTG-binding factor (PBF) is overexpressed in thyroid, pituitary and breast tumours. Critically, high PBF expression is associated with reduced disease-specific survival in thyroid cancer. However, the mechanisms responsible for regulating PBF expression are unknown. In this...

ea0031p153 | Neoplasia, cancer and late effects | SFEBES2013

Functional induction of the oestrogen-regulated PTTG1-binding factor in colorectal cancer

Kwan Perkin , Read Martin , Seed Robert , Ryan Gavin , Smith Vicki , Watkins Rachel , Lu Wenli , Ward Stephen , Watkinson John , Franklyn Jayne , Boelaert Kristien , McCabe Christopher

PTTG1-binding factor (PBF) is an oestrogen-regulated proto-oncogene that is overexpressed in thyroid, breast and pituitary tumours. The precise role of PBF in tumourigenesis, however, has not been established, nor whether it is also an aetiological factor in non-endocrine cancer. In this study, we investigated PBF function in established colorectal cells and human tumours. Specific binding was evident between the tumour suppressor p53 and both endogenous and exogenous PBF in H...

ea0028oc3.8 | Obesity, thyroid and Addison's disease | SFEBES2012

Dietary factors augment the ability of the proto-oncogene PBF to induce goitrogenesis and hyperplasia in vivo

Read Martin , Smith Vicki , Lewy Greg , Ryan Gavin , Sharma Neil , Seed Robert , Fong Jim , Kwan Perkin , Warfield Adrian , Leadbeater Wendy , Watkinson John , Franklyn Jayne , Boelaert Kristien , McCabe Chris

Nodular thyroid disease is common and its pathogenesis remains poorly understood. Previously, we showed that thyroid-targeted overexpression of the proto-oncogene PTTG-Binding Factor (PBF) induced striking thyroid gland enlargement in transgenic mice (PBF-Tg)1. We have now investigated whether dietary factors influence goitrogenesis and the development of hyperplastic lesions in PBF-Tg mice. The mean weight of thyroids (5.8±0.9 mg; n=70) from 7 week old ...

ea0028p334 | Thyroid | SFEBES2012

PBF is a novel regulator of the thyroid hormone transporter MCT8

Smith Vicki , Read Martin , Lewy Gregory , Fong Jim , Seed Robert , Sharma Neil , Kwan Perkin , Ryan Gavin , Darras Veerle , Boelaert Kristien , Franklyn Jayne , McCabe Christopher

Within the basolateral membrane of thyroid follicular epithelial cells, two transporter proteins are important for thyroid hormone (TH) biosynthesis. Initially, sodium iodide symporter (NIS) delivers iodide from the bloodstream into the thyroid and, following biosynthesis, monocarboxylate transporter 8 (MCT8) mediates secretion of TH from the thyroid gland. NIS-mediated radioiodine uptake is also critical in the treatment of thyroid tumours and metastases. We have previously d...